CONTENTS:
- What's in a name? The ethical implications and opportunities in diagnosing an infant with neonatal abstinence syndrome (NAS) [Editorial]. Oei J.L., Blythe S., Dicair L., Didden D., Preisz A., Lantos J., p. 4-6.
- Feasibility and effectiveness of deprescribing benzodiazepines and Z-drugs: systematic review and meta-analysis. Soni A., Thiyagarajan A., Reeve J., p. 7-16.
- Practitioner and digitally delivered interventions for reducing hazardous and harmful alcohol consumption in people not seeking alcohol treatment: a systematic review and network meta-analysis. Beyer F.R., Kenny R.P.W., Johnson E., Caldwell D.M., Garnett C., Rice S., et al., p. 17-29.
- Emotion regulation in substance use disorders: a systematic review and meta-analysis. Stellern J., Xiao K.B., Grennell E., Sanches M., Gowin J.L., Sloan M.E., p. 30-47.
- Modeling the impact of COVID-19 pandemic-driven increases in alcohol consumption on health outcomes and hospitalization costs in the United States. Barbosa C., Dowd W.N., Neuwahl S.J., Rehm J., Imtiaz S., Zarkin G.A., p. 48-60.
- Behavioral stability of alcohol consumption and socio-demographic correlates of change among a nationally representative cohort of US adults. Puka K., Buckley C., Mulia N., Purshouse R.C., Lasserre A.M., Kerr W., et al., p. 61-70.
- Effects of 10 add-on HF-rTMS treatment sessions on alcohol use and craving among detoxified inpatients with alcohol use disorder: a randomized sham-controlled clinical trial. Hoven M., Schluter R.S., Schellekens A.F., van Holst R.J., Goudriaan A.E., p. 71-85.
- Using the alcohol use disorders identification test to predict hospital admission for alcohol-related conditions in the Danish general population: a record-linkage study. Brummer J., Bloomfield K., Karriker-Jaffe K.J., Pedersen M.M., Hesse M., p. 86-94.
- Commentary on Brummer et al.: When using screening tools, it is important to be aware of what you are screening for. Callinan S., Livingston M., p. 95-96.
- The association between buprenorphine treatment duration and mortality: a multi-site cohort study of people who discontinued treatment. Glanz J.M., Binswanger I.A., Clarke C.L., Nguyen A.P., Ford M.A., Ray G.T., et al., p. 97-107.
- Commentary on Glanz et al.: Longer buprenorphine treatment duration is associated with lower rates of opioid overdose, but can we address barriers to staying in treatment? Nielsen S., Larney S., p. 108-109.
- Impacts of recreational cannabis legalization on cannabis use: a longitudinal discordant twin study. Zellers S.M., Ross J.M., Saunders G.R.B., Ellingson J.M., Anderson J.E., Corley R.P., et al., p. 110-118.
- Prioritizing measures to assess performance of drug treatment services: a Delphi process with funders, treatment providers and service-users. Stirling R., Nathan S., Ritter A., p. 119-127.
- Education plays a crucial role in the pathway from poverty to smoking: a Mendelian randomization study. Shi X., Yuan W., Cao Q., Cui W., p. 128-139.
- Non-cigarette combustible tobacco use and its associations with subsequent cessation of smoking among daily cigarette smokers: findings from the International Tobacco Control Four Country Smoking and Vaping Surveys (2016-20). Li L., Borland R., Cummings K.M., Hyland A., Le Grande M., Fong G.T., et al., p. 140-148.
- Roles of parental smoking and family structure for the explanation of socio-economic inequalities in adolescent smoking. Legleye S., Bricard D., Khlat M., p. 149-159.
- Impact of vaping restrictions in public places on smoking and vaping in the United States - Evidence using a difference-in-differences approach. Cheng K.W., Liu F., Pesko M.F., Levy D.T., Fong G.T., Cummings K.M., p. 160-166.
- Adolescent substance use and high school noncompletion: exploring the nature of the relationship using a discordant twin design. Davis C.N., Gizer I.R., Lynskey M.T., Statham D.J., Heath A.C., Martin N.G., et al., p. 167-176.
- Toward an ontology of tobacco, nicotine and vaping products. Cox S., West R., Notley C., Soar K., Hastings J., p. 177-188.
- Algorithmic accountability on social media platforms in the context of alcohol-related health behavior change. Russell A.M., Bergman B.G., Colditz J.B., Massey P.M., p. 189-190.
- Adolescent cannabis use in the context of legalization debate in Chile. Mundt A.P., Contreras L., Ibanez C., p. 190-192.
- On generating adequate counterfactuals for national policy evaluations. A response to Mundt et al. Rivera-Aguirre A., Castillo-Carniglia A., Laqueur H.S., Rudolph K.E., Martins S.S., Ramirez J., et al., p. 192-194.
- The need for a more inclusive and objective approach in developing a core outcomes set for opioid use disorder. Kelley A.T., Incze M.A., p. 194-195.
- Response to Kelley & Incze: there is certainly more work to do for the OUD-COS. Karnik N.S., p. 196.